IDDF2019-ABS-0218 Evaluation on the protection effect of the vismisco in the liver damage induced by paracetamol in mice experiment

Nhung Bui Thi Quynh, Song Nguyen Van
{"title":"IDDF2019-ABS-0218 Evaluation on the protection effect of the vismisco in the liver damage induced by paracetamol in mice experiment","authors":"Nhung Bui Thi Quynh, Song Nguyen Van","doi":"10.1136/gutjnl-2019-iddfabstracts.99","DOIUrl":null,"url":null,"abstract":"Background This study was conducted to evaluate the hepatoprotective and antioxidant effects of Vismisco (extracted from Vigna radiata (L.) Wilczek, Smilax glabra roxb, Scoparia dulcis L.) in the liver damage induced by paracetamol in mice experiment. Aim Study the hepatoprotective effect of Vismisco on the paracetamol-induced hepatotoxicity. Methods Swiss albino mice weighing 25 ± 2 gram were divided into three groups of ten animals; Group 1: oral distilled water of 0.2 ml/10g; Group 2: oral distilled water and take paracetamol 400 mg/kg; Group 3: oral Silymarin at the dose of 140 mg/kg/day and take paracetamol 400 mg/kg; Group 4: oral Vismisco at the dose of 0.6g/kg/day and take paracetamol 400 mg/kg; Group 5: oral Vismisco at the dose of 1.8g/kg/day and take paracetamol 400 mg/kg. Swiss albino mice were oral with a single dose of 400mg/kg paracetamol to induce toxicity, while Vismisco administered in a dose of 0.6g/kg/day and 1.8g/kg/day. Animals were treated daily by the oral route of administration one a day in the morning for successive 8 days and observed once daily. On the 8th day after taking 2 hours of reagent, mice were given oral paracetamol dose of 400 mg/kg. Mice were sacrificed 48h after paracetamol oral to determine serum ALT, AST hepatic content of malonyl dialdehyde (MDA) and liver histopathology. Results The 8 days pretreatment of Vismisco at the oral dose of 0,6g/kg and 1,8g/kg increases the detoxified function of the liver and reduces the increasing level of AST, ALT reduces the increasing level of hepatic MDA, reduced the inflammation, hepatocellular necrosis which was induced by paracetamol. Conclusions Vismisco has the hepatoprotective effect from oxidative damages induced by reducing the generation of free radicals in the metabolic process of paracetamol, interrupt the lipid peroxidation of cellular membranes.","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"115 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2019-iddfabstracts.99","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background This study was conducted to evaluate the hepatoprotective and antioxidant effects of Vismisco (extracted from Vigna radiata (L.) Wilczek, Smilax glabra roxb, Scoparia dulcis L.) in the liver damage induced by paracetamol in mice experiment. Aim Study the hepatoprotective effect of Vismisco on the paracetamol-induced hepatotoxicity. Methods Swiss albino mice weighing 25 ± 2 gram were divided into three groups of ten animals; Group 1: oral distilled water of 0.2 ml/10g; Group 2: oral distilled water and take paracetamol 400 mg/kg; Group 3: oral Silymarin at the dose of 140 mg/kg/day and take paracetamol 400 mg/kg; Group 4: oral Vismisco at the dose of 0.6g/kg/day and take paracetamol 400 mg/kg; Group 5: oral Vismisco at the dose of 1.8g/kg/day and take paracetamol 400 mg/kg. Swiss albino mice were oral with a single dose of 400mg/kg paracetamol to induce toxicity, while Vismisco administered in a dose of 0.6g/kg/day and 1.8g/kg/day. Animals were treated daily by the oral route of administration one a day in the morning for successive 8 days and observed once daily. On the 8th day after taking 2 hours of reagent, mice were given oral paracetamol dose of 400 mg/kg. Mice were sacrificed 48h after paracetamol oral to determine serum ALT, AST hepatic content of malonyl dialdehyde (MDA) and liver histopathology. Results The 8 days pretreatment of Vismisco at the oral dose of 0,6g/kg and 1,8g/kg increases the detoxified function of the liver and reduces the increasing level of AST, ALT reduces the increasing level of hepatic MDA, reduced the inflammation, hepatocellular necrosis which was induced by paracetamol. Conclusions Vismisco has the hepatoprotective effect from oxidative damages induced by reducing the generation of free radicals in the metabolic process of paracetamol, interrupt the lipid peroxidation of cellular membranes.
vismisco对扑热息痛致小鼠肝损伤保护作用的实验评价
本研究旨在研究紫花苜蓿(Vigna radiata, L.)提取物Vismisco的保肝和抗氧化作用。Wilczek, Smilax glabra roxb, Scoparia dulcis L.)对扑热息痛致小鼠肝损伤的影响。目的研究Vismisco对扑热息痛所致肝毒性的保护作用。方法体重为25±2 g的瑞士白化小鼠分为3组,每组10只;第一组:口服蒸馏水0.2 ml/10g;第二组:口服蒸馏水并服用扑热息痛400mg /kg;3组:口服水飞蓟素140 mg/kg/d,同时服用扑热息痛400 mg/kg;第4组:口服Vismisco 0.6g/kg/d,同时服用扑热息痛400 mg/kg;第五组:口服维思乐1.8g/kg/d,同时口服扑热息痛400 mg/kg。对瑞士白化病小鼠口服400mg/kg扑热息痛单次诱导毒性,Vismisco分别给药0.6g/kg/d和1.8g/kg/d。动物每天口服给药,每天1次,早上给药,连续8 d,每天观察1次。给药2小时后第8天,小鼠口服扑热息痛剂量400 mg/kg。口服扑热息痛48h后处死小鼠,测定血清ALT、AST、丙二醛(MDA)含量及肝脏组织病理学变化。结果Vismisco口服剂量0.6 g/kg和1.8 g/kg预处理8 d,可提高肝脏解毒功能,降低AST、ALT升高水平,降低肝脏MDA升高水平,减轻扑热息痛引起的炎症、肝细胞坏死。结论Vismisco通过减少对乙酰氨基酚代谢过程中自由基的产生,阻断细胞膜脂质过氧化作用,对肝脏氧化损伤具有保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信